CLAIM #36967 · Eli Lilly and Company (LLY) · 2024Q4 earnings call · Feb 6, 2025 · due Dec 31, 2025
“As Dave referred to earlier, in terms of set bound, we expect adherence to be long here based upon the firsthand experiences that consumers have.”
Patrik Jonsson · President of Lilly Cardiometabolic Health and Lilly USA
PENDING
graded after results covering Dec 31, 2025 are reported
Verify independently
SEC filings for LLY ↗ · Claim quote is verbatim from the 2024Q4 earnings call.